Brilacidin: Phase IIb start

Next month, Cellceutix will begin a double-blind, U.S. Phase IIb trial to compare brilacidin vs. Cubicin daptomycin in about 200-215 patients

Read the full 213 word article

How to gain access

Continue reading with a
two-week free trial.